Invited talks: In silico simulation for manufacturing processes
| 09:00-09:40 | Digitalization in pharmaceutical product and process design: from advanced simulations to deep learning and cloudbased intelligence Johannes Khinast, Graz University of Technology, Austria |
| 09:40-10:20 | Digital Process Design Sean Bermingham, Process System Enterprise (PSE), London, United Kingdom |
| 10:20-11:00 | Modelling and simulation of fluid-bed processes Stefan Heinrich, Hamburg University of Technology, Germany |
Invited talks: Nanofabrication technologies
| 09:00-09:40 | Manufacturing fibres at all scales for healthcare Mohan Edirisinghe, UCL Mechanical Engineering, London, United Kingdom |
| 09:40-10:20 | Advances in electrospinning Nalin de Silva, Sri Lanka Institute of Nanotechnology, Sri Lanka |
| 10:20-11:00 | Advanced microfluidic platforms for respiratory research: bridging in vivo and in vitro interfaces Josue Sznitman, Department of Biomedical Engineering, Israel Institute of Technology, Haifa, Israel |
Short talks: Determined in December 2019
Short talks: Determined in December 2019
ADRITELF award session
| 11:30-12:00 | International ADRITELF Award 2020 Maria Edvige Sangalli To be determined in March 2020 |
Plenary lecture
Invited talk
| 12:00-13:00 | Oral drug delivery systems: from irrelevance to top-selling products and ongoing challenges Andrea Gazzaniga, Biopharmaceuticals and Pharmaceutical Technology Laboratory, University of Milan, Italy |
Invited talks: Dermal and transdermal delivery
| 15:00-15:40 | Pickering emulsions Marie-Alexandrine Bolzinger, Claude Bernard University Lyon, France |
| 15:40-16:20 | Microarray patches for high-dose drug delivery: targeting global healthcare challenges Ryan F. Donnelly, School of Pharmacy, Queen's University Belfast, United Kingdom |
| 16:20-17:00 | Improved vaccine immunogenicity through microneedle delivery Michael Schrader, Vaxess, Boston, MA, USA |
Invited talks: Continuous manufacturing
| 15:00-15:40 | Redundant process control strategy in pharmaceutical continuous manufacturing Victoria Pauli, Novartis, Basel, Switzerland |
| 15:40-16:20 | Implementing continuous manufacturing into a factory for solid dosage forms Clemens Stief, Pfizer, Freiburg, Germany |
| 16:20-17:00 | Continuous manufacturing of solid dosage forms; opportunities and controversies Kendal Pitt, GlazoSmithKline, Ware, United Kingdom |